Evidence map›Paper›PMID 33684445›Full record

ArticleThe Journal of biological chemistry

The exo-β-N-acetylmuramidase NamZ from Bacillus subtilis is the founding member of a family of exo-lytic peptidoglycan hexosaminidases.

Maraike Müller, Matthew Calvert, Isabel Hottmann, Robert Maria Kluj, Tim Teufel, Katja Balbuchta, Alicia Engelbrecht, Khaled A Selim, Qingping Xu, Marina Borisova and 2 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Novel Thermophilic Species ofLife (Basel, Switzerland) · 2026
    Article
  3. Article
  4. ACS infectious diseases · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Maraike MüllerInterfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen, Germany.
Matthew CalvertChemical Biology of Carbohydrates, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany; Deutsches Zentrum für Infektionsforschung (DZIF), Standort Hannover-Braunschweig, Germany; Department of Chemistry, Saarland University, Saarbrücken, Germany.
Isabel HottmannInterfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen, Germany.
Robert Maria KlujInterfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen, Germany.
Tim TeufelInterfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen, Germany.
Katja BalbuchtaInterfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen, Germany.
Alicia EngelbrechtInterfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen, Germany.
Khaled A SelimInterfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen, Germany; Chemistry of Natural and Microbial Products Department, Pharmaceutical and Drug Industries Research Division, National Research Center, Giza, Egypt.
Qingping XuGM/CA @ APS, Argonne National Laboratory, Lemont, Illinois, USA.
Marina BorisovaInterfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen, Germany.
Alexander TitzChemical Biology of Carbohydrates, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany; Deutsches Zentrum für Infektionsforschung (DZIF), Standort Hannover-Braunschweig, Germany; Department of Chemistry, Saarland University, Saarbrücken, Germany.
Christoph MayerInterfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen, Germany. Electronic address: christoph.mayer@uni-tuebingen.de.
University of Tübingen · DEGerman Center for Infection Research · DEArgonne National Laboratory · USNational Research Centre · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endo-β-N-acetylmuramidases, commonly known as lysozymes, are well-characterized antimicrobial enzymes that catalyze an endo-lytic cleavage of peptidoglycan; i.e., they hydrolyze the β-1,4-glycosidic bonds connecting N-acetylmuramic acid (MurNAc) and N-acetylglucosamine (GlcNAc). In contrast, little is known about exo-β-N-acetylmuramidases, which catalyze an exo-lytic cleavage of β-1,4-MurNAc entities from the non-reducing ends of peptidoglycan chains. Such an enzyme was identified earlier in the bacterium Bacillus subtilis, but the corresponding gene has remained unknown so far. We now report that ybbC of B. subtilis, renamed namZ, encodes the reported exo-β-N-acetylmuramidase. A ΔnamZ mutant accumulated specific cell wall fragments and showed growth defects under starvation conditions, indicating a role of NamZ in cell wall turnover and recycling. Recombinant NamZ protein specifically hydrolyzed the artificial substrate para-nitrophenyl β-MurNAc and the peptidoglycan-derived disaccharide MurNAc-β-1,4-GlcNAc. Together with the exo-β-N-acetylglucosaminidase NagZ and the exo-muramoyl-l-alanine amidase AmiE, NamZ degraded intact peptidoglycan by sequential hydrolysis from the non-reducing ends. A structure model of NamZ, built on the basis of two crystal structures of putative orthologs from Bacteroides fragilis, revealed a two-domain structure including a Rossmann-fold-like domain that constitutes a unique glycosidase fold. Thus, NamZ, a member of the DUF1343 protein family of unknown function, is now classified as the founding member of a new family of glycosidases (CAZy GH171; www.cazy.org/GH171.html). NamZ-like peptidoglycan hexosaminidases are mainly present in the phylum Bacteroidetes and less frequently found in individual genomes within Firmicutes (Bacilli, Clostridia), Actinobacteria, and γ-proteobacteria.

Indexed as

AcetylglucosamineBacillus subtilisCrystallography, X-RayGlycoside HydrolasesHydrolysisMuramic AcidsPeptidoglycanProtein ConformationAcetylglucosamineendo-N-acetylmuramidaseGlycoside HydrolasesMuramic AcidsN-acetylmuramic acidPeptidoglycancell wall recyclingexo-lytic glycosidaselysozymeN-acetylglucosaminidaseN-acetylmuramidaseN-acetylmuramoyl amidasepeptidoglycan hydrolaseRossmann-fold

Identifiers

PMID33684445
PMCPMC8054146
OpenAlexW3133978539

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.